 | Form 4 Filings | Insider Buys | Significant Buys | Penny Stocks Insider Buying | Insider Sales |
| Insider Buy Sell Ratios | Stock Options | Insider Trading Stock Screener | Insider Trading Graph View | Insider Watch |
Insider Trading - NovaBay Pharmaceuticals Inc. (NBY)
| | "Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise" - Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-10 Sale | 2019-06-13 06:03 am | NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director | 63,492 | $2.5325 | $160,793 | 0 (Indirect Direct) | View |
| 2019-06-11 Sale | 2019-06-13 9:32 pm | NovaBay Pharmaceuticals Inc. | NBY | Pioneer Pharma (Hong Kong) Co Ltd 10% Owner | 24,326 | $4.04 | $98,277 | 5,188,421 (Direct) | View |
| 2019-06-11 Sale | 2019-06-13 9:46 pm | NovaBay Pharmaceuticals Inc. | NBY | Fu Jian Ping 10% Owner | 380,954 | $3.84 | $1,462,863 | 5,302,350 (Direct) | View |
| 2019-06-10 Sale(A) | 2019-10-28 4:29 pm | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin CEO | 47,500 | $3.03 | $143,925 | 3,405 (Direct) | View |
| 2019-06-10 Sale(A) | 2019-10-28 4:30 pm | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 33,155 | $3.2206 | $106,778 | 0 (Direct) | View |
| 2020-08-01 Sale | 2020-08-04 6:04 pm | NovaBay Pharmaceuticals Inc. | NBY | Fu Jian Ping 10% Owner | 1,302,350 | $1.23 | $1,601,891 | 4,000,000 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2017-01-25 Option Award | 2017-01-26 6:43 pm | 2018-01-31 2027-01-25 | NovaBay Pharmaceuticals Inc. | NBY | PAULSON THOMAS J CFO | 116,000 | $3.6 | 310,788 (Direct) | View |
| 2017-01-25 Option Award | 2017-01-26 6:48 pm | 2018-01-31 2027-01-25 | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin VP | 143,000 | $3.6 | 278,160 (Direct) | View |
| 2017-06-02 Option Award | 2017-06-06 5:34 pm | 2017-01-31 2027-06-02 | NovaBay Pharmaceuticals Inc. | NBY | SIECZKAREK MARK M CEO | 250,000 | $2.35 | 250,000 (Direct) | View |
| 2017-07-03 Option Award | 2017-07-07 4:20 pm | 2017-08-01 2027-07-03 | NovaBay Pharmaceuticals Inc. | NBY | Li Xinzhou Director 10% Owner | 5,248 | $3.75 | 5,248 (Direct) | View |
| 2017-07-17 Option Award | 2017-08-01 3:58 pm | 2017-07-17 2027-07-17 | NovaBay Pharmaceuticals Inc. | NBY | McGovern John Joseph CFO | 100,000 | $3.8 | 100,000 (Direct) | View |
| 2017-09-14 Exercise | 2017-09-18 7:53 pm | 2017-01-31 2026-06-06 | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin VP | 20,000 | $2.78 | 278,160 (Direct) | View |
| 2017-12-14 Option Award | 2018-01-08 6:21 pm | 2018-12-14 2027-12-14 | NovaBay Pharmaceuticals Inc. | NBY | STUART LEWIS J Chief Commercial Officer | 100,000 | $3.42 | 100,000 (Direct) | View |
| 2017-12-14 Option Award | 2018-01-08 6:29 pm | 2018-08-01 2027-12-14 | NovaBay Pharmaceuticals Inc. | NBY | STUART LEWIS J Chief Commercial Officer | 10,000 | $3.42 | 10,000 (Direct) | View |
| 2017-01-03 Option Award | 2018-01-19 5:29 pm | 2017-01-03 2027-01-03 | NovaBay Pharmaceuticals Inc. | NBY | Ma Yonghao Director | 20,326 | $3.24 | 23,629 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-01 5:21 pm | 2019-05-31 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | McGovern John Joseph CFO | 90,000 | $2.2 | 190,000 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-01 5:34 pm | 2019-05-31 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin VP | 190,000 | $2.2 | 345,710 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 1:59 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director | 20,000 | $2.2 | 62,697 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 2:10 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Li Xinzhou Director 10% Owner | 20,000 | $2.2 | 25,248 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 2:16 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Liu Yanbin Director | 20,000 | $2.2 | 20,000 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 2:24 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Ma Yonghao Director | 20,000 | $2.2 | 43,629 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 4:18 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Maderis Gail J Director | 20,000 | $2.2 | 84,213 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 4:22 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Zavodnick Todd Erik Director | 20,000 | $2.2 | 53,698 (Direct) | View |
| 2018-05-31 Option Award | 2018-06-04 4:27 pm | 2018-06-30 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director | 20,000 | $2.2 | 35,244 (Direct) | View |
| 2018-10-09 Option Award | 2018-10-11 4:30 pm | 2018-10-09 2028-10-09 | NovaBay Pharmaceuticals Inc. | NBY | McGovern John Joseph CFO CEO | 250,000 | $1.45 | 440,000 (Direct) | View |
| 2019-06-10 Exercise | 2019-06-12 9:36 pm | 2019-05-31 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin VP | 47,500 | $2.02 | 0 (Direct) | View |
| 2019-06-10 Exercise | 2019-06-12 9:49 pm | 2019-05-31 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 23,405 | $2.2 | 0 (Direct) | View |
| 2019-06-10 Exercise | 2019-06-12 9:49 pm | 2018-06-02 2027-06-02 | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 9,750 | $2.35 | 0 (Direct) | View |
| 2019-07-30 Option Award | 2019-08-06 08:18 am | N/A N/A | NovaBay Pharmaceuticals Inc. | NBY | SIECZKAREK MARK M Former Director and Officer | 167,938 | $0 | 1,156,883 (Direct) | View |
| 2019-05-30 Option Award | 2019-10-28 4:24 pm | 2019-05-30 2029-05-30 | NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director | 20,000 | $0.3 | 20,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-10-28 4:25 pm | 2019-05-30 2029-05-30 | NovaBay Pharmaceuticals Inc. | NBY | SIECZKAREK MARK M Director | 20,000 | $0.3 | 20,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-10-28 4:25 pm | 2019-05-30 2029-05-30 | NovaBay Pharmaceuticals Inc. | NBY | Maderis Gail J Director | 20,000 | $0.3 | 20,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-10-28 4:27 pm | 2019-05-30 2029-05-30 | NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director | 20,000 | $0.3 | 20,000 (Direct) | View |
| 2019-05-30 Option Award | 2019-10-28 4:28 pm | 2019-05-30 2029-05-30 | NovaBay Pharmaceuticals Inc. | NBY | Li Xinzhou Director 10% Owner | 20,000 | $0.3 | 20,000 (Direct) | View |
| 2019-06-10 Option Award | 2019-10-28 4:29 pm | N/A N/A | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin CEO | 47,500 | $2.02 | 3,405 (Direct) | View |
| 2019-06-10 Exercise | 2019-10-28 4:29 pm | 2019-05-31 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Hall Justin CEO | 47,500 | $2.02 | 3,405 (Direct) | View |
| 2019-06-10 Option Award | 2019-10-28 4:30 pm | N/A N/A | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 23,405 | $2.2 | 0 (Direct) | View |
| 2019-06-10 Option Award | 2019-10-28 4:30 pm | N/A N/A | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 9,750 | $2.35 | 0 (Direct) | View |
| 2019-06-10 Exercise | 2019-10-28 4:30 pm | 2019-05-31 2028-05-31 | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 23,405 | $2.2 | 0 (Direct) | View |
| 2019-06-10 Exercise | 2019-10-28 4:30 pm | 2018-06-02 2027-06-02 | NovaBay Pharmaceuticals Inc. | NBY | Raleigh Jason Philip CFO | 9,750 | $2.35 | 0 (Direct) | View |
| 2019-05-30 Option Award | 2019-10-30 4:31 pm | 2019-05-30 2029-05-30 | NovaBay Pharmaceuticals Inc. | NBY | Zavodnick Todd Erik Director | 20,000 | $0.3 | 20,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-29 5:00 pm | 2020-05-26 2030-05-26 | NovaBay Pharmaceuticals Inc. | NBY | Sit Swan Director | 20,000 | $0.89 | 20,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-29 5:01 pm | 2020-05-26 2030-05-26 | NovaBay Pharmaceuticals Inc. | NBY | Freiman Paul E. Director | 20,000 | $0.89 | 20,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-29 5:02 pm | 2020-05-26 2030-05-26 | NovaBay Pharmaceuticals Inc. | NBY | Wang Xiaopei Director | 20,000 | $0.89 | 20,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-29 5:02 pm | 2020-05-26 2030-05-26 | NovaBay Pharmaceuticals Inc. | NBY | Li Xinzhou Director 10% Owner | 20,000 | $0.89 | 20,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-29 5:03 pm | 2020-05-26 2030-05-26 | NovaBay Pharmaceuticals Inc. | NBY | Zheng Yenyou Director | 20,000 | $0.89 | 20,000 (Direct) | View |
| 2020-05-26 Option Award | 2020-05-29 5:04 pm | 2020-05-26 2030-05-26 | NovaBay Pharmaceuticals Inc. | NBY | WU MIJIA Director | 20,000 | $0.89 | 20,000 (Direct) | View |